In a study in which C57BL/6J mice inoculated with 106 mouse breast cancer E0771 cells in the mammary gland fat pad, oral intake of EGCG at 50–100 mg/kg/day for 4 weeks reduced tumor weight, capillary density and tumor VEGF expression by 65, 30 and 23%, respectively, compared to control. Here, VEGFA is linked to neoplasm.